第一单位：
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
作者：
Liny,John [1]
;
Hannah,Smith [1]
;
Maran,Ilanchezhian [1]
;
Robin,Lockridge [2]
;
Karlyne M,Reilly [1]
;
Margarita,Raygada [1]
;
Eva,Dombi [1]
;
Abby,Sandler [1]
;
Barbara J,Thomas [1]
;
John,Glod [1]
;
Markku,Miettinen [1]
;
Taryn,Allen [1]
;
Josh,Sommer [3]
;
Joan,Levy [3]
;
Shannon,Lozinsky [3]
;
David,Dix [4]
;
Eric,Bouffet [5]
;
Shannon,MacDonald [6]
;
Debraj,Mukherjee [7]
;
Carl H,Snyderman [8]
;
Nicholas R,Rowan [7]
;
Robert,Malyapa [9]
;
Deric M,Park [10]
;
Christopher,Heery [11]
;
Paul A,Gardner [8]
;
Gregory M,Cote [6]
;
Sarah,Fuller [1]
;
John A,Butman [12]
;
Sadhana,Jackson [1]
;
James L,Gulley [13]
;
Brigitte C,Widemann [1]
;
Mary Frances,Wedekind [1]
作者单位：
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
[1]
Clinical Research Directorate (CRD), Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
[2]
Chordoma Foundation, Durham, North Carolina, USA.
[3]
BC Children's Hospital, Vancouver, British Columbia, Canada.
[4]
The Hospital for Sick Children, Toronto, Ontario, Canada.
[5]
Massachusetts General Hospital, Boston, Massachusetts, USA.
[6]
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
[7]
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
[8]
University of Maryland Medical Center, Baltimore, Maryland, USA.
[9]
University of Chicago, Chicago, Illinois, USA.
[10]
Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
[11]
Radiology and Imaging Sciences, The National Institutes of Health, Bethesda, Maryland, USA.
[12]
Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
[13]
DOI
10.1002/pbc.30358
PMID
37347686
发布时间
2025-01-04
换一批
换一批
